Syros Pharmaceuticals Inc. (SYRS) Fundamentals

Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in a non-coding regulatory region of the genome controlling the activation and repression of genes. It is primarily involved in the segments of the pharmaceutical, biotechnology, and other related markets that address gene control and cancer. The Company operates only in the United States.
SHARE INFORMATION
Market Cap$ 43,973,332
Shares Outstanding62,819,046
Float48,270,997
Percent Float76.84%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 23,488,000
Latest Fiscal EPS$ -1.37
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions244
Institutional Holdings Date2022-04-30
Institutional Bought Previous 3 Months2,708,823
Institutional Holdings Percent115.8%
Institutional Sold Previous 3 Months5,212,516
Insider Holdings Date2022-03-31
Insider Bought Previous 3 Months2,565,000
Insider Holdings Percent2.3
Insider Sold Previous 3 Months2,208
Insider Shares Owned1,430,963
TRADING INFO
52 Week High$ 7.03
52 Week Low$ 0.65
52 Week High Change$ -87.52
21 Day Moving Average$ 0.9095
21 Day Extended Moving Average$ 0.886522
50 Day Moving Average$ 1.0124
50 Day Extended Moving Average$ 1.0953
200 Day Moving Average$ 2.9848
200 Day Extended Moving Average$ 2.8563
10 Day Average Volume848,943
20 Day Average Volume1,096,449
30 Day Average Volume1,032,473
50 Day Average Volume916,749
Alpha-0.040931
Beta2.1235
Standard Deviation0.236978
R20.179928
7 Day Price Change$ -0.1412
7 Day Percent Change-16.79%
21 Day Price Change$ -0.1827
21 Day Percent Change-20.7%
30 Day Price Change$ -0.24
30 Day Percent Change-25.53%
Month to Date Price Change$ -0.1418
Month to Date Percent Change-16.84%
Quarter to Date Price Change$ -0.49
Quarter to Date Percent Change-41.18%
180 Day Price Change$ -3.18
180 Day Percent Change-81.96%
200 Day Price Change$ -3.43
200 Day Percent Change-83.05%
Year to Date Price Change$ -2.56
Year to Date Percent Change-78.53%

Syros Pharmaceuticals Inc. (SYRS) Key Ratios

PROFITABILITY
EBIT Margin-351.9%
EBITDA Margin-339.0%
Pre-Tax Profit Margin-2,522.3%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 18,661,000
Revenue Per Share$ 0.2971
Revenue (3 Years)$ 151.57
Revenue (5 Years)$ 86.73
FINANCIAL STRENGTH
Price to Tangible Book0.50
Total Debt To Equity0.80
Int Coverage-21.20
Current Ratio4.30
Leverage Ratio1.90
Quick Ratio4.20
Long Term Debt To Capital0.43
VALUATION MEASURES
PE Ratio-0.50
Enterprise Value$ -20,570,196
Price to Sales2.3564
Price to Free Cash-0.60
PE High Last 5 Years-3.90
Price To Book0.50
Price To Cash Flow0.00
PE Low Last 5 Years-2.50
Price to Tangible Book0.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover7.30
Invoice Turnover0.00
Assets Turnover0.10
Return Assets-45.38
Return on Equity-102.12
Return on Capital-53.87

Syros Pharmaceuticals Inc. (SYRS) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEONancy A. Simonian
Emplyoees124
Last AuditUE
CIK0001556263
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address35 CambridgePark Drive
4th Floor
Cambridge, MA 2140
Websitehttps://www.syros.com
Facsimile-
Telephone+1 617 744-1340
Email-
Your Recent History
NASDAQ
SYRS
Syros Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220520 11:13:41